AXSOME THERAPEUTICS INC (AXSM) Stock Income Statement
NASDAQ:AXSM - Nasdaq - US05464T1043 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 432.16M | 385.69M | 270.60M | 50.04M | 0.00 | |||
| Cost Of Goods | 36.80M | 33.30M | 26.07M | 5.20M | N/A | |||
| Gross Profit | 395.36M | 352.39M | 244.53M | 44.84M | N/A | |||
| Operating Expenses | 667.93M | 632.95M | 476.36M | 224.14M | 124.71M | |||
| Research and Development | 195.03M | 187.08M | 97.94M | 57.95M | 58.06M | |||
| Selling, General, and Administrative Expenses | 435.48M | 411.36M | 323.12M | 158.75M | 66.65M | |||
| Operating Income | -272.57M | -280.56M | -231.82M | -179.30M | -124.71M | |||
| Interest Income/Expense | -7.92M | -6.57M | -6.45M | -7.33M | -5.70M | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | -500.00K | 0.00 | |||
| Income Before Taxes | -278.19M | -287.13M | -238.28M | -187.13M | -130.40M | |||
| Income Tax | 85.00K | 85.00K | 960.00K | N/A | N/A | |||
| Net Income | -278.27M | -287.22M | -239.24M | -187.13M | -130.40M | |||
| EBITDA | -264.31M | -272.60M | -224.99M | -174.90M | -124.63M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.77 | -5.99 | -5.27 | -4.60 | -3.47 | |||
| Non GAAP EPS | -5.77 | -5.99 | -5.20 | -4.57 | -3.47 | |||
| Statistics | ||||||||
| Gross Profit Margin | 91.49% | 91.37% | 90.37% | 89.61% | N/A | |||
| Profit Margin | -64.39% | -74.47% | -88.41% | -373.96% | N/A | |||
| Operating Profit Margin | -63.07% | -72.74% | -85.67% | -358.31% | N/A | |||
All data in USD